Association of Protein Intake with Recurrence and Survival Following Primary Treatment of Ovarian Cancer

Malnutrition is common during treatment of ovarian cancer, and 1 in 3 patients report multiple symptoms affecting food intake after primary treatment. Little is known about diet posttreatment in relation to ovarian cancer survival; however, general recommendations for cancer survivors are to maintai...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal of clinical nutrition 2023-07, Vol.118 (1), p.50-58
Hauptverfasser: Johnston, Elizabeth A., Ibiebele, Torukiri I., Friedlander, Michael L., Grant, Peter T., van der Pols, Jolieke C., Webb, Penelope M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 58
container_issue 1
container_start_page 50
container_title The American journal of clinical nutrition
container_volume 118
creator Johnston, Elizabeth A.
Ibiebele, Torukiri I.
Friedlander, Michael L.
Grant, Peter T.
van der Pols, Jolieke C.
Webb, Penelope M.
description Malnutrition is common during treatment of ovarian cancer, and 1 in 3 patients report multiple symptoms affecting food intake after primary treatment. Little is known about diet posttreatment in relation to ovarian cancer survival; however, general recommendations for cancer survivors are to maintain a higher level of protein intake to support recovery and minimize nutritional deficits. To investigate whether intake of protein and protein food sources following primary treatment of ovarian cancer is associated with recurrence and survival. Intake levels of protein and protein food groups were calculated from dietary data collected ∼12 mo postdiagnosis using a validated FFQ in an Australian cohort of women with invasive epithelial ovarian cancer. Disease recurrence and survival status were abstracted from medical records (median 4.9 y follow-up). Cox proportional hazards regression was used to calculate adjusted HRs and 95% CIs for protein intake and progression-free and overall survival. Among 591 women who were progression-free at 12 mo follow-up, 329 (56%) subsequently experienced cancer recurrence and 231 (39%) died. A higher level of protein intake was associated with better progression-free survival (>1–1.5 compared with ≤1 g/kg body weight, HRadjusted: 0.69, 95% CI: 0.48, 1.00; >1.5 compared with ≤1 g/kg, HRadjusted: 0.61, 95% CI: 0.41, 0.90; >20% compared with ≤20% total EI from protein, HRadjusted: 0.77, 95% CI: 0.61, 0.96). There was no evidence for better progression-free survival with any particular protein food sources. There was a suggestion of better overall survival among those with higher total intakes of animal-based protein foods, particularly dairy products (HR: 0.71; 95% CI: 0.51, 0.99 for highest compared with lowest tertiles of total dairy intake). After primary treatment of ovarian cancer, a higher level of protein intake may benefit progression-free survival. Ovarian cancer survivors should avoid dietary practices that limit intake of protein-rich foods.
doi_str_mv 10.1016/j.ajcnut.2023.05.002
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2810916124</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002916523488958</els_id><sourcerecordid>2810916124</sourcerecordid><originalsourceid>FETCH-LOGICAL-c436t-da366f4021e9c4c862a377b27b4556958fef003262ee2da97b3c49edbb2c23503</originalsourceid><addsrcrecordid>eNp9kc1O3DAURi3UqkynfQNUWeqGTYJ_YifZIKERtEhIVEDXluPcFIeMDbYziLevR6EsumB1Jet8n-1zETqipKSEypOx1KNxcyoZYbwkoiSEHaAVbXlTcEbqD2hF8lHRUikO0ecYR0Ioqxr5CR3ymlayFu0K3Z_F6I3VyXqH_YB_BZ_AOnzpkn4A_GzTPb4BM4cAzgDWrse3c9jZnZ7whZ8m_2zdn5yyWx1e8F0Anbbg0r7qeqeD1Q5vdE6GL-jjoKcIX1_nGv2-OL_b_Cyurn9cbs6uClNxmYpecymHijAKralMI5nmdd2xuquEkK1oBhgI4UwyANbrtu64qVrou44ZxgXha3S89D4G_zRDTGpro4Fp0g78HBVrKMlKsomMfv8PHf0cXH5dprjIdXWea1QtlAk-xgCDelx-qyhR-02oUS2bUPtNKCJU1p5j317L524L_Vvon_oMnC4AZBs7C0FFY_eSexvAJNV7-_4NfwFBi5uZ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2835235728</pqid></control><display><type>article</type><title>Association of Protein Intake with Recurrence and Survival Following Primary Treatment of Ovarian Cancer</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Johnston, Elizabeth A. ; Ibiebele, Torukiri I. ; Friedlander, Michael L. ; Grant, Peter T. ; van der Pols, Jolieke C. ; Webb, Penelope M.</creator><creatorcontrib>Johnston, Elizabeth A. ; Ibiebele, Torukiri I. ; Friedlander, Michael L. ; Grant, Peter T. ; van der Pols, Jolieke C. ; Webb, Penelope M. ; Ovarian cancer Prognosis And Lifestyle (OPAL) Study Group</creatorcontrib><description>Malnutrition is common during treatment of ovarian cancer, and 1 in 3 patients report multiple symptoms affecting food intake after primary treatment. Little is known about diet posttreatment in relation to ovarian cancer survival; however, general recommendations for cancer survivors are to maintain a higher level of protein intake to support recovery and minimize nutritional deficits. To investigate whether intake of protein and protein food sources following primary treatment of ovarian cancer is associated with recurrence and survival. Intake levels of protein and protein food groups were calculated from dietary data collected ∼12 mo postdiagnosis using a validated FFQ in an Australian cohort of women with invasive epithelial ovarian cancer. Disease recurrence and survival status were abstracted from medical records (median 4.9 y follow-up). Cox proportional hazards regression was used to calculate adjusted HRs and 95% CIs for protein intake and progression-free and overall survival. Among 591 women who were progression-free at 12 mo follow-up, 329 (56%) subsequently experienced cancer recurrence and 231 (39%) died. A higher level of protein intake was associated with better progression-free survival (&gt;1–1.5 compared with ≤1 g/kg body weight, HRadjusted: 0.69, 95% CI: 0.48, 1.00; &gt;1.5 compared with ≤1 g/kg, HRadjusted: 0.61, 95% CI: 0.41, 0.90; &gt;20% compared with ≤20% total EI from protein, HRadjusted: 0.77, 95% CI: 0.61, 0.96). There was no evidence for better progression-free survival with any particular protein food sources. There was a suggestion of better overall survival among those with higher total intakes of animal-based protein foods, particularly dairy products (HR: 0.71; 95% CI: 0.51, 0.99 for highest compared with lowest tertiles of total dairy intake). After primary treatment of ovarian cancer, a higher level of protein intake may benefit progression-free survival. Ovarian cancer survivors should avoid dietary practices that limit intake of protein-rich foods.</description><identifier>ISSN: 0002-9165</identifier><identifier>EISSN: 1938-3207</identifier><identifier>DOI: 10.1016/j.ajcnut.2023.05.002</identifier><identifier>PMID: 37146759</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Body weight ; Cancer ; cancer survivors ; cohort studies ; Dairy products ; diet ; Dietary intake ; Food ; Food groups ; Food intake ; Food sources ; Health services ; Malnutrition ; Mathematical analysis ; Medical records ; nutrition ; Ovarian cancer ; protein intake ; Proteins ; Signs and symptoms ; Survival ; survival analysis</subject><ispartof>The American journal of clinical nutrition, 2023-07, Vol.118 (1), p.50-58</ispartof><rights>2023 American Society for Nutrition</rights><rights>Copyright © 2023 American Society for Nutrition. Published by Elsevier Inc. All rights reserved.</rights><rights>Copyright American Society for Clinical Nutrition, Inc. Jul 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c436t-da366f4021e9c4c862a377b27b4556958fef003262ee2da97b3c49edbb2c23503</citedby><cites>FETCH-LOGICAL-c436t-da366f4021e9c4c862a377b27b4556958fef003262ee2da97b3c49edbb2c23503</cites><orcidid>0000-0002-9486-5704</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37146759$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Johnston, Elizabeth A.</creatorcontrib><creatorcontrib>Ibiebele, Torukiri I.</creatorcontrib><creatorcontrib>Friedlander, Michael L.</creatorcontrib><creatorcontrib>Grant, Peter T.</creatorcontrib><creatorcontrib>van der Pols, Jolieke C.</creatorcontrib><creatorcontrib>Webb, Penelope M.</creatorcontrib><creatorcontrib>Ovarian cancer Prognosis And Lifestyle (OPAL) Study Group</creatorcontrib><title>Association of Protein Intake with Recurrence and Survival Following Primary Treatment of Ovarian Cancer</title><title>The American journal of clinical nutrition</title><addtitle>Am J Clin Nutr</addtitle><description>Malnutrition is common during treatment of ovarian cancer, and 1 in 3 patients report multiple symptoms affecting food intake after primary treatment. Little is known about diet posttreatment in relation to ovarian cancer survival; however, general recommendations for cancer survivors are to maintain a higher level of protein intake to support recovery and minimize nutritional deficits. To investigate whether intake of protein and protein food sources following primary treatment of ovarian cancer is associated with recurrence and survival. Intake levels of protein and protein food groups were calculated from dietary data collected ∼12 mo postdiagnosis using a validated FFQ in an Australian cohort of women with invasive epithelial ovarian cancer. Disease recurrence and survival status were abstracted from medical records (median 4.9 y follow-up). Cox proportional hazards regression was used to calculate adjusted HRs and 95% CIs for protein intake and progression-free and overall survival. Among 591 women who were progression-free at 12 mo follow-up, 329 (56%) subsequently experienced cancer recurrence and 231 (39%) died. A higher level of protein intake was associated with better progression-free survival (&gt;1–1.5 compared with ≤1 g/kg body weight, HRadjusted: 0.69, 95% CI: 0.48, 1.00; &gt;1.5 compared with ≤1 g/kg, HRadjusted: 0.61, 95% CI: 0.41, 0.90; &gt;20% compared with ≤20% total EI from protein, HRadjusted: 0.77, 95% CI: 0.61, 0.96). There was no evidence for better progression-free survival with any particular protein food sources. There was a suggestion of better overall survival among those with higher total intakes of animal-based protein foods, particularly dairy products (HR: 0.71; 95% CI: 0.51, 0.99 for highest compared with lowest tertiles of total dairy intake). After primary treatment of ovarian cancer, a higher level of protein intake may benefit progression-free survival. Ovarian cancer survivors should avoid dietary practices that limit intake of protein-rich foods.</description><subject>Body weight</subject><subject>Cancer</subject><subject>cancer survivors</subject><subject>cohort studies</subject><subject>Dairy products</subject><subject>diet</subject><subject>Dietary intake</subject><subject>Food</subject><subject>Food groups</subject><subject>Food intake</subject><subject>Food sources</subject><subject>Health services</subject><subject>Malnutrition</subject><subject>Mathematical analysis</subject><subject>Medical records</subject><subject>nutrition</subject><subject>Ovarian cancer</subject><subject>protein intake</subject><subject>Proteins</subject><subject>Signs and symptoms</subject><subject>Survival</subject><subject>survival analysis</subject><issn>0002-9165</issn><issn>1938-3207</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp9kc1O3DAURi3UqkynfQNUWeqGTYJ_YifZIKERtEhIVEDXluPcFIeMDbYziLevR6EsumB1Jet8n-1zETqipKSEypOx1KNxcyoZYbwkoiSEHaAVbXlTcEbqD2hF8lHRUikO0ecYR0Ioqxr5CR3ymlayFu0K3Z_F6I3VyXqH_YB_BZ_AOnzpkn4A_GzTPb4BM4cAzgDWrse3c9jZnZ7whZ8m_2zdn5yyWx1e8F0Anbbg0r7qeqeD1Q5vdE6GL-jjoKcIX1_nGv2-OL_b_Cyurn9cbs6uClNxmYpecymHijAKralMI5nmdd2xuquEkK1oBhgI4UwyANbrtu64qVrou44ZxgXha3S89D4G_zRDTGpro4Fp0g78HBVrKMlKsomMfv8PHf0cXH5dprjIdXWea1QtlAk-xgCDelx-qyhR-02oUS2bUPtNKCJU1p5j317L524L_Vvon_oMnC4AZBs7C0FFY_eSexvAJNV7-_4NfwFBi5uZ</recordid><startdate>202307</startdate><enddate>202307</enddate><creator>Johnston, Elizabeth A.</creator><creator>Ibiebele, Torukiri I.</creator><creator>Friedlander, Michael L.</creator><creator>Grant, Peter T.</creator><creator>van der Pols, Jolieke C.</creator><creator>Webb, Penelope M.</creator><general>Elsevier Inc</general><general>American Society for Clinical Nutrition, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7T7</scope><scope>7TS</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>P64</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-9486-5704</orcidid></search><sort><creationdate>202307</creationdate><title>Association of Protein Intake with Recurrence and Survival Following Primary Treatment of Ovarian Cancer</title><author>Johnston, Elizabeth A. ; Ibiebele, Torukiri I. ; Friedlander, Michael L. ; Grant, Peter T. ; van der Pols, Jolieke C. ; Webb, Penelope M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c436t-da366f4021e9c4c862a377b27b4556958fef003262ee2da97b3c49edbb2c23503</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Body weight</topic><topic>Cancer</topic><topic>cancer survivors</topic><topic>cohort studies</topic><topic>Dairy products</topic><topic>diet</topic><topic>Dietary intake</topic><topic>Food</topic><topic>Food groups</topic><topic>Food intake</topic><topic>Food sources</topic><topic>Health services</topic><topic>Malnutrition</topic><topic>Mathematical analysis</topic><topic>Medical records</topic><topic>nutrition</topic><topic>Ovarian cancer</topic><topic>protein intake</topic><topic>Proteins</topic><topic>Signs and symptoms</topic><topic>Survival</topic><topic>survival analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Johnston, Elizabeth A.</creatorcontrib><creatorcontrib>Ibiebele, Torukiri I.</creatorcontrib><creatorcontrib>Friedlander, Michael L.</creatorcontrib><creatorcontrib>Grant, Peter T.</creatorcontrib><creatorcontrib>van der Pols, Jolieke C.</creatorcontrib><creatorcontrib>Webb, Penelope M.</creatorcontrib><creatorcontrib>Ovarian cancer Prognosis And Lifestyle (OPAL) Study Group</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Physical Education Index</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of clinical nutrition</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Johnston, Elizabeth A.</au><au>Ibiebele, Torukiri I.</au><au>Friedlander, Michael L.</au><au>Grant, Peter T.</au><au>van der Pols, Jolieke C.</au><au>Webb, Penelope M.</au><aucorp>Ovarian cancer Prognosis And Lifestyle (OPAL) Study Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Association of Protein Intake with Recurrence and Survival Following Primary Treatment of Ovarian Cancer</atitle><jtitle>The American journal of clinical nutrition</jtitle><addtitle>Am J Clin Nutr</addtitle><date>2023-07</date><risdate>2023</risdate><volume>118</volume><issue>1</issue><spage>50</spage><epage>58</epage><pages>50-58</pages><issn>0002-9165</issn><eissn>1938-3207</eissn><abstract>Malnutrition is common during treatment of ovarian cancer, and 1 in 3 patients report multiple symptoms affecting food intake after primary treatment. Little is known about diet posttreatment in relation to ovarian cancer survival; however, general recommendations for cancer survivors are to maintain a higher level of protein intake to support recovery and minimize nutritional deficits. To investigate whether intake of protein and protein food sources following primary treatment of ovarian cancer is associated with recurrence and survival. Intake levels of protein and protein food groups were calculated from dietary data collected ∼12 mo postdiagnosis using a validated FFQ in an Australian cohort of women with invasive epithelial ovarian cancer. Disease recurrence and survival status were abstracted from medical records (median 4.9 y follow-up). Cox proportional hazards regression was used to calculate adjusted HRs and 95% CIs for protein intake and progression-free and overall survival. Among 591 women who were progression-free at 12 mo follow-up, 329 (56%) subsequently experienced cancer recurrence and 231 (39%) died. A higher level of protein intake was associated with better progression-free survival (&gt;1–1.5 compared with ≤1 g/kg body weight, HRadjusted: 0.69, 95% CI: 0.48, 1.00; &gt;1.5 compared with ≤1 g/kg, HRadjusted: 0.61, 95% CI: 0.41, 0.90; &gt;20% compared with ≤20% total EI from protein, HRadjusted: 0.77, 95% CI: 0.61, 0.96). There was no evidence for better progression-free survival with any particular protein food sources. There was a suggestion of better overall survival among those with higher total intakes of animal-based protein foods, particularly dairy products (HR: 0.71; 95% CI: 0.51, 0.99 for highest compared with lowest tertiles of total dairy intake). After primary treatment of ovarian cancer, a higher level of protein intake may benefit progression-free survival. Ovarian cancer survivors should avoid dietary practices that limit intake of protein-rich foods.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>37146759</pmid><doi>10.1016/j.ajcnut.2023.05.002</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-9486-5704</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0002-9165
ispartof The American journal of clinical nutrition, 2023-07, Vol.118 (1), p.50-58
issn 0002-9165
1938-3207
language eng
recordid cdi_proquest_miscellaneous_2810916124
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Body weight
Cancer
cancer survivors
cohort studies
Dairy products
diet
Dietary intake
Food
Food groups
Food intake
Food sources
Health services
Malnutrition
Mathematical analysis
Medical records
nutrition
Ovarian cancer
protein intake
Proteins
Signs and symptoms
Survival
survival analysis
title Association of Protein Intake with Recurrence and Survival Following Primary Treatment of Ovarian Cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T13%3A49%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Association%20of%20Protein%20Intake%20with%20Recurrence%20and%20Survival%20Following%20Primary%20Treatment%20of%20Ovarian%20Cancer&rft.jtitle=The%20American%20journal%20of%20clinical%20nutrition&rft.au=Johnston,%20Elizabeth%20A.&rft.aucorp=Ovarian%20cancer%20Prognosis%20And%20Lifestyle%20(OPAL)%20Study%20Group&rft.date=2023-07&rft.volume=118&rft.issue=1&rft.spage=50&rft.epage=58&rft.pages=50-58&rft.issn=0002-9165&rft.eissn=1938-3207&rft_id=info:doi/10.1016/j.ajcnut.2023.05.002&rft_dat=%3Cproquest_cross%3E2810916124%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2835235728&rft_id=info:pmid/37146759&rft_els_id=S0002916523488958&rfr_iscdi=true